Encyclopedia of Signaling Molecules

2012 Edition
| Editors: Sangdun Choi

Protein Tyrosine Kinase-6 (PTK6)

  • Amanda Harvey
Reference work entry
DOI: https://doi.org/10.1007/978-1-4419-0461-4_305


Historical Background

The intracellular protein tyrosine kinase, PTK6 (also known as the breast tumor kinase, Brk), has been implicated in the development and progression of a number of different tumor types. First identified in three separate studies in the early 1990s, it was initially found in a study to determine which tyrosine kinases were expressed in human melanocytes and then the full-length sequence was subsequently cloned from metastatic breast cancer using a screen to identify novel kinases that were expressed in tumors, but not normal breast tissue. Identification of the murine orthologue, Sik, in mouse intestinal cells was achieved by the generation of a library of kinase catalytic domains.

PTK6 is related to the Src family of protein kinases and belongs to a distinct class of enzymes which includes Frk and SRMS (reviewed in Brauer and Tyner 2010). Under normal physiological conditions, PTK6 expression is highly controlled and is...

This is a preview of subscription content, log in to check access.


  1. Aubele M, Auer G, Walch AK, Munro A, Atkinson MJ, Braselmann H, et al. PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. Br J Cancer. 2007;96(5):801–7.PubMedGoogle Scholar
  2. Brauer PM, Tyner AL. Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK. Biochim Biophys Acta. 2010;1806(1):66–73. doi:10.1016/j.bbcan.2010.02.003.PubMedGoogle Scholar
  3. Castro NE, Lange CA. Breast tumor kinase and extracellular-signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells. Breast Cancer Res. 2010;12(4):R60. doi:10.1186/bcr2622.PubMedGoogle Scholar
  4. Chakraborty G, Jain S, Kundu GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res. 2008;68(1):152–61. doi:10.1158/0008-5472.CAN-07-2126.PubMedGoogle Scholar
  5. Chen HY, Shen CH, Tsai YT, Lin FC, Huang YP, Chen RH. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol Cell Biol. 2004;24(24):10558–72.PubMedGoogle Scholar
  6. Derry JJ, Prins GS, Ray V, Tyner AL. Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene. 2003;22(27):4212–20.PubMedGoogle Scholar
  7. Hanahan D, Weinberg RA. Hallmarks of cancer. Cell. 2000;100:57–70.PubMedGoogle Scholar
  8. Harvey AJ, Crompton MR. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene. 2003;22:5006–10.PubMedGoogle Scholar
  9. Harvey AJ, Crompton MR. The Brk tyrosine kinase as a novel therapeutic target in breast cancer: opportunities and challenges. Anticancer Drugs. 2004;15(2):107–11.PubMedGoogle Scholar
  10. Harvey AJ, Pennington C, Porter S, Burmi RS, Edwards DR, Court W, et al. Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage. Am J Pathol. 2009;175(3):1226–34.PubMedGoogle Scholar
  11. Irie HY, Shrestha Y, Selfors LM, Frye F, Iida N, Wang Z, et al. PTK6 regulates IGF-1-induced anchorage-independent survival. PLoS One. 2010;5(7):e11729. doi:10.1371/journal.pone.0011729.PubMedGoogle Scholar
  12. Kamalati T, Jolin HE, Fry MJ, Crompton MR. Expression of the Brk tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signaling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene. 2000;19(48):5471–6.PubMedGoogle Scholar
  13. Kim HI, Lee S-T. Oncogenic functions of PTK6 are enhanced by its targeting to plasma membrane but abolished by its targeting to nucleus. J Biochem. 2009;146(1):133–9. doi:10.1093/jb/mvp050.Google Scholar
  14. Lukong KE, Larocque D, Tyner AL, Richard S. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J Biol Chem. 2005;280(46):38639–47.PubMedGoogle Scholar
  15. Mitchell PJ, Barker KT, Martindale JE, Kamalati T, Low PN, Page MJ, et al. Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene. 1994;9(8):2383–90.PubMedGoogle Scholar
  16. Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CJ. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res. 2007;67(9):4199–209.PubMedGoogle Scholar
  17. Ostrander JH, Daniel AR, Lange CA. Brk/PTK6 signaling in normal and cancer cell models. Curr Opin Pharmacol. 2010;10(6):662–9. doi:10.1016/j.coph.2010.08.007.PubMedGoogle Scholar
  18. Tupper J, Crompton MR, Harvey AJ. Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes. Arch Dermatol Res. 2011. doi:10.1007/s00403-010-1118-4.Google Scholar
  19. Wang TC, Jee SH, Tsai TF, et al. Role of breast tumor kinase in the in vitro differentiation of HaCaT cell. Br J Dermatol. 2005;153(2):282–9.PubMedGoogle Scholar
  20. Xiang B, Chatti K, Qiu H, Lakshmi B, Krasnitz A, Hicks J, et al. Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Proc Natl Acad Sci USA. 2008;105(34):12463–8.PubMedGoogle Scholar
  21. Zhang P, Ostrander JH, Faivre EJ, Olsen A, Fitzimmons D, Lange CA. Regulated association of protein kinase B/Akt with breast tumor kinase. J Biol Chem. 2005;280(3):1982–91.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Brunel Institute for Cancer Genetics and PharmacogenomicsBrunel UniversityWest LondonUK